chugai pharmaceutic-unsp adr
Transactions by CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY) in the last 6 months
ASKA Pharmaceutical Co.Ltd. (TSE:4514) signed a contract to acquire manufacturing and marketing approval right of two antithyroid drugs from Chugai Pharmaceutical Co. Ltd. (TSE:4519) on April 3, 2015. The transaction is expected to close on October 1, 2015.
iPS Portal, Inc. announced the signing of a share subscription agreement for the issue of A class preferred shares for gross proceeds of ¥1.42 billion in the end of February 2015. The transaction included participation from 13 investors, Shimadzu Corporation, Eisai Co., Ltd., Ajinomoto Co., Inc., Sysmex Corporation, Shin Nippon Biomedical Laboratories, Ltd., SCREEN Holdings Co., Ltd., Toho Holdings Co., Ltd., Chugai Pharmaceutical Co., Ltd., Horiba, Ltd., Daiichi Jitsugyo ...
Chugai Pharmaceutical Co. Ltd.
Daiichi Jitsugyo Co. Ltd.
Daiwa Corporate Investment Co., Ltd.
Eisai Co., Ltd.
SCREEN Holdings Co., Ltd.
Shin Nippon Biomedical Laboratories, Ltd.
SMBC Venture Capital Co., Ltd.
Sumitomo Mitsui Banking Corp., Investment Arm
Toho Holdings Co., Ltd.
NanoCarrier Co., Ltd. (TSE:4571) announced a private placement of 389,400 shares at ¥1,284 per share with new investor, Chugai Pharmaceutical Co. Ltd. for gross proceeds of ¥499,989,600 on February 24, 2015. The investor will acquire 0.96% stake of the company through this transaction. The net proceeds from the transaction will be ¥494,989,600, after deducting estimated amount of issuance fees of ¥5,000,000, which includes registration fees and license taxes ¥ 2,500,000 ...
|No competitor information is available for CHGCY.|
|View Industry Companies|
|Price/Cash Flow||--||Not Meaningful|